NILE尼羅財經
HIMSNILE61C排名#51/65

HIMS 今日盤勢平淡,NILE 評分維持 60.7,無變動。

HIMS logo
USNYSE醫療保健Drug Manufacturers - Specialty & Generic

Hims & Hers Health, Inc. (HIMS)

Hims & Hers Health, Inc. operates as a consumer-first health and wellness platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, Canada, Germany, the Republic of Ireland, France, Spain, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides personalized health and wellness products; over-the-counter drug and device products, cosmetics, and supplement products primarily focusing on general wellness, skincare, sexual health and wellness, and hair care under the Hims & Hers brand name; and laboratory testing services to measure a set of biomarkers. Additionally, it offers medical consultation, post-consultation support services, and delivery of laboratory testing results services. Further, the company provides treatments and products for various chronic conditions related to hormone health, weight loss, dermatology, and mental health. The company offers its products through retail partnerships, in stores, and online. Hims & Hers Health, Inc. is based in San Francisco, California.

61/ 100

NILE 因子評分

覆蓋股排名 #51 / 65 ・ 分數勝過 22% 的已評個股

vs 全體護城河 E成長 C

2026/9/8 更新 ・ 資料覆蓋率 62% ・ 評分方法

分享這檔評分:ThreadsFacebook

部分因子當期缺資料,其權重已按比例分攤到其餘因子,不計為 0 分。

護城河編輯評定#63/6542
數值 42權重 56.5貢獻 23.7
NILE 編輯評定
未來成長率編輯評定#24/6585
數值 20.0%權重 43.5貢獻 37.0
NILE 編輯預估
估值(預估本益比)財報計算
數值 權重 0.0貢獻 0.0
最近一期財報與收盤價
自由現金流利潤率財報計算
數值 權重 0.0貢獻 0.0
最近一期財報

評分為資料整理與分析觀點,非投資建議,不構成任何買賣要約。

想看完整的護城河與成長論述?前往 評分分析;財報數字與情境估值在 財務與估值